Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G7IF
|
|||
Drug Name |
VLX1570
|
|||
Synonyms |
SCKXBVLYWLLALY-ZSIIYVIPSA-N; VLX-1570; 1431280-51-1; BCP18900
Click to Show/Hide
|
|||
Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90.0] | Phase 1 | [1] | |
Company |
VivoLux, Ashburn, VA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H17F2N3O6
|
|||
Canonical SMILES |
C=CC(=O)N1CCC(=CC2=CC(=C(C=C2)F)[N+](=O)[O-])C(=O)C(=CC3=CC(=C(C=C3)F)[N+](=O)[O-])C1
|
|||
InChI |
1S/C23H17F2N3O6/c1-2-22(29)26-8-7-16(9-14-3-5-18(24)20(11-14)27(31)32)23(30)17(13-26)10-15-4-6-19(25)21(12-15)28(33)34/h2-6,9-12H,1,7-8,13H2/b16-9+,17-10+
|
|||
InChIKey |
SCKXBVLYWLLALY-CZCYGEDCSA-N
|
|||
CAS Number |
CAS 1956378-23-6
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.